| |
β-Amyloid (1-42), human  |
|
|

| Cat. No. |
Size |
Price |
Figures |
RP10017-0.5 mg
| 0.5 mg | $ 118.75 | HPLC: 20060721145613 (PDF) MS: 20060721145553 (PDF) MSDS: 20080923043843 (PDF) EXAMPLE:
 Zoom
References:
- Murphy GM Jr, et al. Development of a monoclonal antibody specific for the COOH-terminal of beta-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol. May 1994; 144(5): 1082-1088.
- Ambroggio EE, et al. Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys J. Apr 2005; 88(4): 2706-2713.
- Hulstaert F, et al. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology. May 1999; 52(8): 1555-1562.
|
|---|
| Full Name | |
Sequence (one-letter code) |
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA | Sequence (three-letter code) | {ASP}{ALA}{GLU}{PHE}{ARG}{HIS}{ASP}{SER}{GLY}{TYR} {GLU}{VAL}{HIS}{HIS}{GLN}{LYS}{LEU}{VAL}{PHE}{PHE} {ALA}{GLU}{ASP}{VAL}{GLY}{SER}
{ASN}{LYS}{GLY}{ALA}{ILE} {ILE}{GLY}{LEU}{MET}{VAL}{GLY}{GLY}{VAL}{VAL}{ILE} {ALA} | | Description | This peptide is well suited to the quantitative determination of A 42 peptide. Alzheimer’s disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain. The major protein component of these plaques is beta amyloid peptide (A), a 40- to 43- amino-acid peptide cleaved from amyloid precursor protein by secretase (BACE) and a putative (gamma) secretase. Increased release of the ‘longer forms’ of A peptide, A 42 and A 43, which have a greater tendency to aggregate than A 40, occurs in individuals expressing certain genetic mutations, expressing certain ApoE alleles or may other, still undiscovered factors. |
|---|
| Solubility | Insoluble in water, may be dissolved in any buffer with pH greater than 9 |
|---|
| Formula | C203H311N55O60S1 | | M.W. | 4514.1 | | Cas | 107761-42-2 |
|---|
| Purity | > 95% | | Storage | Store at -20°C | | Notes | Predominant form found in the brains of patients with Alzheimer's Disease and Down's Syndrome |
| * For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|